(Q42917478)

11 November 2017

title

Effect of tetrabenazine use on restless legs syndrome (English)

1 reference

11 November 2017

William G. Ondo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817597

7 July 2024

Judy J. Jia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20817597

7 July 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20817597

7 July 2024

publication date

1 October 2010

1 reference

full work available at URL

11 November 2017

number of pages

2

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:S138994571000287X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.05.009

https://api.elsevier.com/content/article/PII:S138994571000287X?httpAccept=text/plain

7 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.05.009

7 July 2024

1 reference

11 November 2017

volume

11

1 reference

11 November 2017

issue

9

1 reference

11 November 2017

page(s)

958-959

1 reference

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.05.009

Restless legs syndrome: pathophysiology, diagnosis and treatment

7 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.05.009

Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome

7 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.05.009

Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease

7 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.05.009

Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in untreated restless legs syndrome (RLS) patients indicates more severe disease and possibly abnormally increased dopamine synthesis

7 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.05.009

Altered dopaminergic profile in the putamen and substantia nigra in restless leg syndrome

7 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.05.009

Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute

7 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.05.009

Spinal cord dopamine receptor expression and function in mice with 6-OHDA lesion of the A11 nucleus and dietary iron deprivation

7 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.SLEEP.2010.05.009

7 July 2024

Identifiers

1 reference

11 November 2017

1 reference